527 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

Page of 11 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ABAT4-aminobutyrate aminotransferaseDisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Tissue enhanced
ABCA1ATP-binding cassette, sub-family A (ABC1), member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
ABCC1ATP-binding cassette, sub-family C (CFTR/MRP), member 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
ABCC2ATP-binding cassette, sub-family C (CFTR/MRP), member 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
ABCC8ATP-binding cassette, sub-family C (CFTR/MRP), member 8Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
ABL1C-abl oncogene 1, non-receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
RAS pathway related proteins
Expressed in all
ACEAngiotensin I converting enzymeCandidate cardiovascular disease genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Group enriched
ACE2Angiotensin I converting enzyme 2Enzymes
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
ACHEAcetylcholinesterase (Yt blood group)Blood group antigen proteins
Enzymes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
ADAAdenosine deaminaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Tissue enriched
ADH1AAlcohol dehydrogenase 1A (class I), alpha polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Tissue enriched
ADH1BAlcohol dehydrogenase 1B (class I), beta polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Group enriched
ADKAdenosine kinaseDisease related genes
Enzymes
FDA approved drug targets
Expressed in all
ADORA1Adenosine A1 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
ADORA3Adenosine A3 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRA1AAdrenoceptor alpha 1AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRA1DAdrenoceptor alpha 1DFDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhanced
ADRA2CAdrenoceptor alpha 2CFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRB1Adrenoceptor beta 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRB2Adrenoceptor beta 2, surfaceFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Mixed
AGTR1Angiotensin II receptor, type 1Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
AKR1C2Aldo-keto reductase family 1, member C2Disease related genes
Enzymes
FDA approved drug targets
Tissue enhanced
AKR1D1Aldo-keto reductase family 1, member D1Disease related genes
Enzymes
FDA approved drug targets
Tissue enriched
ALADAminolevulinate dehydrataseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
ALDH2Aldehyde dehydrogenase 2 family (mitochondrial)Cancer-related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted secreted proteins
Expressed in all
ALKAnaplastic lymphoma receptor tyrosine kinaseCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ALOX5Arachidonate 5-lipoxygenaseEnzymes
FDA approved drug targets
Tissue enhanced
ALPPL2Alkaline phosphatase, placental-like 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
AMY2AAmylase, alpha 2A (pancreatic)Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
ANO1Anoctamin 1, calcium activated chloride channelFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
ANXA1Annexin A1Cancer-related genes
FDA approved drug targets
Plasma proteins
Transporters
Expressed in all
AOC3Amine oxidase, copper containing 3Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
APEX1APEX nuclease (multifunctional DNA repair enzyme) 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
ARAndrogen receptorCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Transcription factors
Tissue enhanced
ATIC5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
ATP1A1ATPase, Na+/K+ transporting, alpha 1 polypeptideCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
ATP2C1ATPase, Ca++ transporting, type 2C, member 1Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Transporters
Expressed in all
ATP4AATPase, H+/K+ exchanging, alpha polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
ATP6V1B2ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2FDA approved drug targets
Transporters
Expressed in all
AVPR1BArginine vasopressin receptor 1BFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Not detected
AVPR2Arginine vasopressin receptor 2Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Mixed
BCHEButyrylcholinesteraseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
BCL2B-cell CLL/lymphoma 2Cancer-related genes
Disease related genes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted membrane proteins
Expressed in all
BCRBreakpoint cluster regionCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Expressed in all
BDKRB2Bradykinin receptor B2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
BLVRBBiliverdin reductase B (flavin reductase (NADPH))Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
BRAFV-raf murine sarcoma viral oncogene homolog BCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Expressed in all
C3Complement component 3Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
C4AComplement component 4A (Rodgers blood group)Blood group antigen proteins
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
C4BComplement component 4B (Chido blood group)Blood group antigen proteins
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all

Page of 11 | next »